Carindacillin
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (2S,5R,6R)-6-([3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 26605-69-6 |
| ATC code | J01CA05 |
| PubChem | CID 93184 |
| ChemSpider | 391995 |
| UNII | 5V278481KE |
| ChEMBL | CHEMBL1200991 |
| Chemical data | |
| Formula | C26H26N2O6S |
| Mol. mass | 494.55 g/mol |
|
|
Carindacillin (INN), also known as Carbenicillin indanyl (USAN) is a penicillin antibiotic. It is a prodrug of carbenicillin.[1]
It is administered orally, as the sodium salt. It is marketed by Pfizer under the brand name Geocillin.
References [edit]
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||